Sam B Bhayani and Louis R Kavoussi

Johns Hopkins Medical Institutions, Baltimore, Maryland, U.S.A.

INTRODUCTION

DIFFERENCES IN LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTIONS

EFFICACY OF TREATMENT OPTIONS COMPLICATIONS OF LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION

POSTCHEMOTHERAPY LAPAROSCOPIC

RETROPERITONEAL LYMPH NODE

DISSECTION

SUMMARY

REFERENCES

COMMENTARY: Jerome P Richie

Surveillance, primary chemotherapy, and open retroperitoneal lymph node dissection all demonstrate equivalent outcomes when applied appropriately. As such, morbidity of the treatment becomes the major factor when selecting treatment.

Despite the proven efficacy of open retroperitoneal lymph node dissection, approximately 70% of patients have pathologically negative nodes, and may derive no therapeutic benefit from surgery.

Laparoscopic retroperitoneal lymph node dissection may represent a minimally invasive alternative to open retroperitoneal lymph node dissection and primary chemotherapy.

0 0

Post a comment